These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9873399)
41. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives. Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150 [TBL] [Abstract][Full Text] [Related]
42. Carbapenem and penem antibiotics. VI. Synthesis and antibacterial activity of 2-heteroaromatic-thiomethyl and 2-carbamoyloxymethyl 1-methylcarbapenems. Imuta M; Itani H; Ona H; Hamada Y; Uyeo S; Yoshida T Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):663-71. PubMed ID: 2070445 [TBL] [Abstract][Full Text] [Related]
43. Novel C-2 substituted carbapenem derivatives. Part I. Synthesis and biological activity of non-aromatic heterocyclic derivatives. Burton G; Clear NJ; Eglington AJ; Guest AW; Hunt E; Naylor A; Pearson MJ; Takle AK J Antibiot (Tokyo); 1996 Dec; 49(12):1258-65. PubMed ID: 9031672 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and antibacterial activity of new 2-substituted penems. I. Nishi T; Higashi K; Takemura M; Sato M J Antibiot (Tokyo); 1993 Nov; 46(11):1740-51. PubMed ID: 8270497 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological properties of 1 beta-methylcarbapenems with N-methylpyrrolidinylthio group at C-2 position. Sunagawa M; Matsumura H; Inoue T; Yamaga H; Fukasawa M J Antibiot (Tokyo); 1992 Jun; 45(6):971-6. PubMed ID: 1500365 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and antibacterial activity of 1 beta-methylcarbapenem having a 1,3-diazabicyclo[3.3.0]octan-4-one moiety, Part II. Oh CH; Lee SC; Park SJ; Lee IK; Nam KH; Lee KS; Chung BY; Cho JH Arch Pharm (Weinheim); 1999 Apr; 332(4):111-4. PubMed ID: 10327883 [TBL] [Abstract][Full Text] [Related]
47. New 1 beta-methylcarbapenems having a hydantoin moiety. Oh CH; Kim HJ; Hong SY; Lee YH; Cho JK; Cho JH Arch Pharm (Weinheim); 1995 Apr; 328(4):385-7. PubMed ID: 7611834 [No Abstract] [Full Text] [Related]
48. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry. Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673 [TBL] [Abstract][Full Text] [Related]
49. Novel C-2 substituted carbapenem derivatives. Part III. Synthesis and biological activity of 2-(functionalised ethenyl, oxyiminomethyl and alpha-[hydroxy]benzyl)-carbapenems. Clear NJ; Davies JS; Eglington AJ; Fell SC; Hinks JD; Hird NW; Hunt E; Moss SF; Pearson MJ J Antibiot (Tokyo); 1997 Mar; 50(3):237-45. PubMed ID: 9127195 [TBL] [Abstract][Full Text] [Related]
50. Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents. Sader HS; Gales AC Drugs; 2001; 61(5):553-64. PubMed ID: 11368281 [TBL] [Abstract][Full Text] [Related]
51. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in-vitro biological activity - part II. Kim SJ; Cho JH; Oh CH Arch Pharm (Weinheim); 2009 Sep; 342(9):528-32. PubMed ID: 19598286 [TBL] [Abstract][Full Text] [Related]
52. Dual-action penems and carbapenems. Corraz AJ; Dax SL; Dunlap NK; Georgopapadakou NH; Keith DD; Pruess DL; Rossman PL; Then R; Unowsky J; Wei CC J Med Chem; 1992 May; 35(10):1828-39. PubMed ID: 1588561 [TBL] [Abstract][Full Text] [Related]
53. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems. Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386 [TBL] [Abstract][Full Text] [Related]
54. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems. Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864 [TBL] [Abstract][Full Text] [Related]
55. Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compounds. Imamura H; Ohtake N; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Kiyonaga H; Suzuki-Sato C; Nakano M; Nagano R; Yamada K; Hashizume T; Morishima H Bioorg Med Chem Lett; 2000 Jan; 10(2):115-8. PubMed ID: 10673092 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392. Ratcliffe RW; Wilkening RR; Wildonger KJ; Waddell ST; Santorelli GM; Parker DL; Morgan JD; Blizzard TA; Hammond ML; Heck JV; Huber J; Kohler J; Dorso KL; St Rose E; Sundelof JG; May WJ; Hammond GG Bioorg Med Chem Lett; 1999 Mar; 9(5):679-84. PubMed ID: 10201828 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and antibacterial activity of 1-substituted-methyl carbapenems. Sendo Y; Kii M; Sakanoue M; Motokawa K; Kimura Y Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2410-8. PubMed ID: 1446363 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and antibacterial activity of new 1beta-methylcarbapenems having the potential for intramolecular nonbonded S...O interactions. Nagao Y; Iimori H; Nam KH; Sano S; Shiro M Chem Pharm Bull (Tokyo); 2001 Dec; 49(12):1660-1. PubMed ID: 11767095 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and in vitro activity of novel quaternary ammonium carbapenems: 2-pyridiniopropyl and 1-pyridinioethyl carbapenems. Ueda Y; Vinet V J Antibiot (Tokyo); 1992 Jun; 45(6):940-53. PubMed ID: 1500362 [TBL] [Abstract][Full Text] [Related]
60. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems. Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]